Image of DXNA logo
  • Contact Us
  • |
  • Careers
    • About DxNA
      • History
      • Mission Statement
    • Executive Team
    • Board of Scientific Advisors
    • Partnering Opportunities
      • Distribution
      • OEM Licensing
      • 3rd Party Integration
    • Careers
    • News & Events
      • DxNA In the News
      • Press Releases
      • Industry Headlines
        • H5N1 - Avian Influenza
        • Malaria
        • Exotic Newcastle DIsease
        • PRRS - Porcine Reproductive and Respiratory Syndrome
        • African Swine Fever
    • Why DxNA
    • Genetic Molecular Analyses
    • Situation Analysis
    • Vital Role of Genetic Testing
    • Overview
    • Biodefense
    • Human Medicine
    • Veterinary Medicine
    • Agriculture
    • Food & Beverage Safety
    • Overview
    • What We Test For
    • Tests & Reagents
    • Request a Test
    • FAQ
    • White Paper
  • Search:
About DxNA
Executive Team
Board of Scientific Advisors
Partnering Opportunities
Careers
News & Events
DxNA In the News
Press Releases
Industry Headlines
H5N1 - Avian Influenza
Malaria
Exotic Newcastle DIsease
PRRS - Porcine Reproductive and Respiratory Syndrome
African Swine Fever

Malaria


Click here to download the DxNA Synopsis on Malaria.

Click here to download The Global Malaria Action Plan: For A Malaria-Free World.

Click here to view a film on the East African Experience in Malaria Prevention and Control featuring Mr. Cyril Boynes, Jr. - Executive Vice President of International Affairs, CORE.

Malaria is a complex and deadly disease that puts approximately 3.3 billion people at risk in 109 countries and territories around the world. In 2000, there were between 350 and 500 million cases of malaria and at least one million deaths world-wide, most of them in African children. In addition to its health toll, malaria places a heavy economic burden on many endemic countries, contributing to the cycle of poverty and limiting economic development. For example, Africa alone is estimated to lose at least US $12 billion per year in direct losses (e.g. illness, treatment, premature death), and many times more than that in lost economic growth.

Following an aborted Global Malaria Eradication campaign in the 1950s – 1970s, malaria received little attention until recently. Over the past decade, there has been substantial progress in raising awareness about malaria. Several countries have demonstrated that it is possible to substantially reduce malariarelated morbidity and mortality. For example, following expanded coverage with LLINs and ACTs, malaria cases and deaths in health facilities in Rwanda declined by more than 50%. Similar results were achieved in Eritrea, Sao Tome and Principe, and Zanzibar (United Republic of Tanzania). -Source: Rollback Malaria Partnership, 2008.

Courtesy: Nets for Life
  • site map
  • |
  • privacy
  • |
  • Copyright © 2012 DxNA LLC